Loading...
XHEL
PIHLIS
Market cap353mUSD
Apr 30, Last price  
13.90EUR
1D
5.70%
1Q
34.95%
Jan 2017
-24.54%
IPO
7.92%
Name

Pihlajalinna Oyj

Chart & Performance

D1W1MN
XHEL:PIHLIS chart
No data to show
P/E
11.40
P/S
0.44
EPS
1.22
Div Yield, %
0.50%
Shrs. gr., 5y
-0.13%
Rev. gr., 5y
6.32%
Revenues
704m
-2.16%
47,300,000104,400,000173,850,000213,327,000399,092,000423,984,000487,764,000518,596,000508,682,000577,774,000690,481,000719,984,000704,400,000
Net income
27m
+378.27%
1,100,0004,400,0001,713,000464,0008,049,0009,515,0003,826,0003,365,0008,687,00020,095,0009,519,0005,729,00027,400,000
CFO
101m
+27.59%
016,425,9999,402,00015,703,00031,190,00033,243,00037,704,00036,840,00047,185,00056,936,00064,882,00079,002,000100,800,000
Dividend
Apr 11, 20240.07 EUR/sh
Earnings
May 14, 2025

Profile

Pihlajalinna Oyj provides social and healthcare services for private persons, companies, insurance companies, municipalities, and hospital districts in Finland. It offers general practitioner and medical specialist services, occupational healthcare, social and healthcare outsourcing, fitness center services, responsible doctor, and remote consultation services, as well as residential and staffing services. Its specialized care and services, include geriatrics, gynecology, psychiatry, youth psychiatry, neurology, internal medicine, radiology, general medicine, opaedics and surgery, internal medicine, urology, cardiology, surgery, plastic surgery, internal medicine cardiology, lung diseases, dialysis, ENT, and orthopedics, as well as emergency and on-call, dental care, substance abuse clinic, and family service center services. Pihlajalinna Oyj was founded in 2001 and is headquartered in Tampere, Finland.
URL
https://www.pihlajalinna.fi/
IPO date
Jun 08, 2015
Employees
7,479
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
704,400
-2.16%
719,984
4.27%
690,481
19.51%
Cost of revenue
205,700
585,902
274,595
Unusual Expense (Income)
NOPBT
498,700
134,082
415,886
NOPBT Margin
70.80%
18.62%
60.23%
Operating Taxes
8,500
3,587
(6,110)
Tax Rate
1.70%
2.68%
NOPAT
490,200
130,495
421,996
Net income
27,400
378.27%
5,729
-39.82%
9,519
-52.63%
Dividends
(2,200)
(1,480)
(8,589)
Dividend yield
0.93%
0.93%
4.46%
Proceeds from repurchase of equity
(900)
(1,475)
BB yield
0.38%
0.77%
Debt
Debt current
31,000
33,750
31,428
Long-term debt
392,800
574,432
598,266
Deferred revenue
20,000
Other long-term liabilities
117,700
21,324
1,478
Net debt
392,900
583,665
598,698
Cash flow
Cash from operating activities
100,800
79,002
64,882
CAPEX
(11,000)
(22,859)
(29,033)
Cash from investing activities
(12,300)
(18,460)
(83,439)
Cash from financing activities
(82,200)
(49,153)
27,429
FCF
440,497
252,423
246,882
Balance
Cash
30,900
24,517
13,128
Long term investments
17,868
Excess cash
Stockholders' equity
31,400
124,591
122,888
Invested Capital
498,500
523,509
524,458
ROIC
95.93%
24.90%
100.01%
ROCE
98.48%
25.21%
78.03%
EV
Common stock shares outstanding
22,479
22,558
22,589
Price
10.50
48.51%
7.07
-17.02%
8.52
-32.59%
Market cap
236,029
47.99%
159,485
-17.13%
192,462
-32.59%
EV
627,129
739,705
790,068
EBITDA
551,800
185,988
461,384
EV/EBITDA
1.14
3.98
1.71
Interest
9,800
11,549
6,831
Interest/NOPBT
1.97%
8.61%
1.64%